Skip to main content

Table 1 The clinical information of the included patients with primary biliary cholangitis

From: Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis

Characteristics

Low risk

High risk

P-value

(N = 42)

(N = 24)

Age (year)

53.31 ± 8.39

55.83 ± 8.83

0.253

Sex

  

0.101

 Male

3 (7.1%)

5 (20.8%)

 

 Female

39 (92.9%)

19 (79.2%)

 

RBC (× 109/L)

4.46 (4.11, 4.59)

4.14 (3.75, 4.48)

0.021

HGB (g/L)

128.5 (121.8, 138.3)

129.5 (109.3, 135.5)

0.268

PLT (× 109/L)

168.5 (131.3, 226.0)

120.5 (90.5, 173.3)

0.066

ALT (IU/L)

19.5 (12.8, 27.5)

39.5 (25.5, 83.5)

 < 0.001

AST (IU/L)

30.0 (23.0, 36.5)

51.0 (37.0, 83.3)

 < 0.001

ALB (g/L)

45.4 (42.8, 47.1)

42.6 (37.5, 45.8)

0.03

ALP (IU/L)

111.5 (87.5, 138.5)

214.0 (131.0, 299.3)

 < 0.001

GGT (IU/L)

44.0 (24.8, 77.5)

129.5 (38.3, 320.5)

0.002

TBiL (μmol/L)

12.8 (9.6, 18.2)

27.7 (21.4, 42.7)

 < 0.001

  1. RBC red blood cell, HGB hemoglobin, PLT platelet, ALT alanine aminotransferase, AST aspartate aminotransferase, ALB albumin, ALP alkaline phosphatase, GGT gamma glutamyl transferase, TBiL total bilirubin